Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

13.44 +0.10 (+0.75%)
Streaming Delayed Price Updated: 9:40 AM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
3 Healthcare Stocks We Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Stocks
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
3 Reasons to Sell IART and 1 Stock to Buy Instead
Integra LifeSciences’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $13.34 per share. This might have investors contemplating their next move. 
Via StockStory
Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
3 Cash-Burning Stocks We’re Skeptical Of
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to... 
Via StockStory
Why Integra LifeSciences (IART) Stock Is Down Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 3.6% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a warning letter regarding violations at... 
Via StockStory
Topics Economy
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
Spotting Winners: Integra LifeSciences (NASDAQ:IART) And Surgical Equipment & Consumables - Specialty Stocks In Q2
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
3 Russell 2000 Stocks We’re Skeptical Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
Integra LifeSciences, IQVIA, Avantor, National Vision, and United Airlines Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. 
Via StockStory
Topics Economy Stocks
IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook
Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $415.6 million. The company expects... 
Via StockStory
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Lawsuit
3 Value Stocks with Warning Signs
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
1 Volatile Stock to Target This Week and 2 We Avoid
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
3 Stocks Under $50 We Approach with Caution
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
Integra (IART) Q2 Revenue Beats by 5%
Via The Motley Fool
Integra LifeSciences Holding (NASDAQ:IART) Reports Q2 2025 Earnings Beat Amid Mixed Market Reaction
Integra LifeSciences (IART) Q2 2025 earnings beat revenue and EPS estimates, but shares dipped pre-market. Strong performance in neurosurgery and wound care segments drives growth. 
Via Chartmill
Topics Earnings
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets
Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $415.6 million. The company expects... 
Via StockStory
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for. 
Via StockStory
3 Profitable Stocks We Think Twice About
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
3 Out-of-Favor Stocks with Open Questions
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
3 Small-Cap Stocks with Mounting Challenges
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Energy
3 Value Stocks Skating on Thin Ice
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
3 Volatile Stocks with Bad Fundamentals
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Surgical Equipment & Consumables - Specialty Stocks Q1 In Review: Integra LifeSciences (NASDAQ:IART) Vs Peers
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.